FDPSP7

Across TCGA pan-cancer cohorts, FDPSP7 RNA differs between tumor and matched normal tissue in 7 of 18 cancer types tested, making tumor–normal expression one of FDPSP7’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where FDPSP7 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FDPSP7 is over-expressed in tumor.

KIRP, HNSC, and UCEC are the cancer types where FDPSP7 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FDPSP7 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRP	All	All	+0.036	<.001	9	view →
HNSC	All	III,IV	+0.088	.010	7	view →
UCEC	All	IV	+0.365	.014	4	view →
STAD	Male	All	+0.210	.003	4	view →
BRCA	Female	All	+0.075	.007	4	view →
LUSC	All	All	+0.105	<.001	3	view →
KIRC	All	All	+0.021	.003	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 7 strongest of 7 lineages.

FDPSP7–KIRP

Open the KIRP breakdown →